We are live on ! Find out more

26 hedge funds and large institutions have $6.77M invested in IN8bio in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

0.08% less ownership

Funds ownership: 0.67%0.58% (-0.08%)

19% less funds holding

Funds holding: 3226 (-6)

34% less capital invested

Capital invested by funds: $10.2M → $6.77M (-$3.45M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
9
Reduced
5
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
-$141K -3,972 Closed
Two Sigma Investments
27
Two Sigma Investments
New York
-$49K -1,384 Closed
Millennium Management
28
Millennium Management
New York
-$38.4K -1,085 Closed
WS
29
Wela Strategies
Georgia
-$21.9K -618 Closed
GSC
30
Ground Swell Capital
South Carolina
-$19.3K -545 Closed
VF
31
Virtu Financial
New York
-$17K -468 Closed
Goldman Sachs
32
Goldman Sachs
New York
-$13.7K -387 Closed
Vontobel Holding
33
Vontobel Holding
Switzerland
-$11.8K -333 Closed
Wells Fargo
34
Wells Fargo
California
-$291 -8 Closed
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
+$160 +5 +250%

INAB Hedge Fund Activity: Q2 2024 in Review

26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q2 2024, worth a combined $6.77M — down 34% from $10.2M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of INAB and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 9 added.

The largest buyer was Alyeska Investment Group, adding an estimated $209K. The largest seller was AIGH Capital Management, cutting an estimated $799K.

  • 26 institutional investors held IN8bio (INAB) as of Q2 2024, down from 32 in Q1 2024.
  • Funds reported $6.77M of IN8bio stock for Q2 2024, down 34% quarter-over-quarter.
  • 3 funds opened new IN8bio positions in Q2 2024 and 9 closed out, a net change of -6 holders.
  • The largest IN8bio buyer in Q2 2024 was Alyeska Investment Group, an estimated $209K added.
  • The largest IN8bio seller in Q2 2024 was AIGH Capital Management, an estimated $799K sold.

Based on aggregated 13F filings for Q2 2024.